• 1. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 2. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 3. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473
• 4. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 5. Distinction of trans–cis photoisomers with comparable optical properties in multiple-state photochromic systems – examining a molecule with three azobenzenes via in situ irradiation NMR spectroscopy?
  Jonas Kind,Lukas Kaltschnee,Martin Leyendecker,Christina M. Thiele Chem. Commun., 2016,52, 12506-12509

Introduction to Compound with CAS No. 1171381-25-1 and Product Name: WFNKWJRRRYFCHD-UHFFFAOYSA-N

Compound with the CAS number 1171381-25-1 and the product name WFNKWJRRRYFCHD-UHFFFAOYSA-N represents a significant advancement in the field of chemical and biomedical research. This compound has garnered considerable attention due to its unique structural properties and potential applications in drug development, particularly in the realm of targeted therapy and molecular recognition. The detailed exploration of this compound's characteristics, synthesis methods, and emerging research findings provides a comprehensive understanding of its significance in modern chemistry and pharmaceutical sciences.

The molecular structure of CAS No. 1171381-25-1 is meticulously designed to exhibit specific interactions with biological targets, making it a promising candidate for various therapeutic applications. Recent studies have highlighted its role in modulating cellular processes, which could lead to novel treatments for a range of diseases. The compound's ability to selectively bind to certain receptors or enzymes underscores its potential as a pharmacological agent. This selectivity is crucial for minimizing side effects and enhancing therapeutic efficacy.

In the context of drug discovery, the product name WFNKWJRRRYFCHD-UHFFFAOYSA-N serves as a unique identifier, facilitating accurate documentation and communication within the scientific community. The compound's synthesis involves sophisticated chemical methodologies that ensure high purity and yield. Advanced techniques such as combinatorial chemistry and high-throughput screening have been employed to optimize its production process. These methods not only improve efficiency but also allow for rapid iteration and refinement of the compound's properties.

One of the most exciting aspects of CAS No. 1171381-25-1 is its potential in addressing unmet medical needs. Current research indicates that this compound may have applications in treating neurological disorders, inflammatory conditions, and even certain types of cancer. Its mechanism of action involves intricate interactions with biological pathways, which are being thoroughly investigated by researchers worldwide. The compound's ability to interfere with disease-causing pathways without disrupting normal cellular functions makes it an attractive option for future drug development.

The field of medicinal chemistry has seen significant advancements due to compounds like WFNKWJRRRYFCHD-UHFFFAOYSA-N. These advancements are driven by a deeper understanding of molecular interactions and the development of innovative synthetic strategies. The compound's structural features enable it to mimic natural biomolecules or block harmful interactions, thereby restoring normal physiological processes. This approach aligns with the broader trend in drug development towards more personalized and precise therapies.

Recent publications have demonstrated the efficacy of CAS No. 1171381-25-1 in preclinical studies, where it showed promising results in animal models of various diseases. These studies not only validate its therapeutic potential but also provide valuable insights into its pharmacokinetic and pharmacodynamic properties. The data collected from these experiments are crucial for designing clinical trials that will further assess its safety and effectiveness in human populations.

The synthesis and characterization of WFNKWJRRRYFCHD-UHFFFAOYSA-N have been supported by cutting-edge analytical techniques such as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry, and X-ray crystallography. These tools provide high-resolution structural information, enabling researchers to understand how the compound interacts with its targets at the molecular level. Such detailed knowledge is essential for optimizing its therapeutic potential and developing new derivatives with improved properties.

The implications of this research extend beyond immediate clinical applications. The development of compounds like CAS No. 1171381-25-1 contributes to our fundamental understanding of biological systems and disease mechanisms. This knowledge can be leveraged to create new classes of drugs that address complex diseases more effectively. Additionally, the methodologies used in its synthesis may be applied to other areas of chemical research, fostering innovation across multiple disciplines.

As interest in targeted therapies grows, compounds like WFNKWJRRRYFCHD-UHFFFAOYSA-N are becoming increasingly important tools for researchers seeking to develop precision medicine approaches. These therapies aim to treat diseases by targeting specific molecular mechanisms underlying them, rather than using broad-spectrum treatments that can have unintended consequences. The unique properties of this compound make it well-suited for such applications, offering hope for more effective and personalized treatments.

In conclusion, CAS No. 1171381-25-1 represents a significant milestone in chemical and biomedical research. Its unique structural features, synthetic methodologies, and therapeutic potential make it a valuable asset in the fight against various diseases. The ongoing research into this compound promises to yield further insights into disease mechanisms and new strategies for treatment. As our understanding continues to evolve, so too will the applications of this remarkable molecule.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)